North America Women's Health Diagnostics Market, By Application (Osteoporosis Testing, OVC Testing, Cervical Cancer Testing, Breast Cancer Testing, Pregnancy, and Fertility Testing, Prenatal Genetic Screening and Carrier Testing, Infectious Disease Testing, STD Testing, Ultrasound Tests), End User (Hospitals, Diagnostic and Imaging Centers, Clinics, Home Care Setting) – Industry Trends and Forecast to 2030.
North America Women's Health Diagnostics Market Analysis and Size
The increase in the incidence of infectious diseases in women in this region is one of the primary factors enhancing market growth. Numerous collaborations among major market players, governments, and other agencies to improve the accessibility of patients to diagnostics of several diseases are anticipated to increase market growth. It has been seen that the surge in early detection of any health issue with the help of digital and mobile mammography, such as MRI, and bone density testing increases the market growth rate.
Data Bridge Market Research analyses that the women's health diagnostics market, which was USD 10.2 billion in 2022, would rise to USD 19.59 billion by 2030 and is expected to undergo a CAGR of 8.50% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
North America Women's Health Diagnostics Market Scope and Segmentation
2023 to 2030
2021 (Customizable to 2015 - 2020)
Revenue in USD Billion, Volumes in Units, Pricing in USD
Application (Osteoporosis Testing, OVC Testing, Cervical Cancer Testing, Breast Cancer Testing, Pregnancy, and Fertility Testing, Prenatal Genetic Screening and Carrier Testing, Infectious Disease Testing, STD Testing, Ultrasound Tests), End User (Hospitals, Diagnostic and Imaging Centers, Clinics, Home Care Setting)
U.S., Canada, and Mexico in North America
Market Players Covered
Siemens (Germany), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (U.S.), BD (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), NeuroLogica Corp.(U.S.), General Electric (U.S.), Quest Diagnostics Incorporated (U.S.), Sysmex India Pvt. Ltd. (Japan), Hitachi, Ltd. (Japan), Canon Inc. (Japan)
Good health of women refers to the complete diagnosis and treatment of illnesses and diseases that may affect a woman's physical and mental well-being. Women's health involves several disorders such as birth control, sexually transmitted infections (STIs), breast cancer, ovarian cancer, gynecology disorders, other female cancers, hormone therapy. There are other issues as well such as osteoporosis, pregnancy and childbirth, and benign conditions affecting the function of the female reproductive organs that need to be maintained for the proper functioning of the system which needs to be identifies positively.
North America Women's Health Diagnostics Market Dynamics
- Increasing Prevalence of Breast Cancer
Breast cancer is the most common cancer in women and second-most-common cancer globally. Each year in the U.S., around 264,000 breast cancer cases are diagnosed in women and about 2,400 in men. The increasing number of cases has resulted in higher sales of test kits for home use, projected to boost the market's revenue growth throughout the forecast period. This increasing prevalence demands a higher need to review women's health diagnostics. Thus, this factor increases the market growth.
- Increasing Adoption of Diagnostic Tests
Most diagnostic and imaging tests are performed at centers, which is anticipated to boost the market's growth. As per the United Nations, Food and Drug Administration (USFDA) article named "Mammography Quality Standards Act and Program (MQSA) National Statistics" updated in 2021, in the U.S., there are around 23,588 accredited units for mammography. Of 13,125 accredited Full Field Digital Mammography and Computed Radiography Units, 10,458 are Digital Breast Tomosynthesis units. Thus, this factor boosts market growth.
- Increasing Strategic Developments Associated with Health Diagnostics
The major market players' numerous strategies are anticipated to enhance the market. For instance, OWN (Oprah Winfrey Network) and its health initiative Own Your Health started an exclusive partnership with Hologic's Project Health Equality public health initiative in 2021. The collaboration will increase awareness about disparities in healthcare quality received by Black women in the U.S. for breast, cervical, and uterine fibroids. Thus, this factor boosts market growth.
- Growing Product Launches by Market Players
Increasing product launches are another major factor in boosting the market's growth. For instance, Roche launched its CE-IVD-approved automated digital pathology algorithms, uPath HER2 (4B5) image analysis, and uPath HER2 Dual ISH image analysis for breast cancer in 2021. These algorithms assist in determining the best treatment strategy for each patient. Thus, this factor boosts market growth.
- High Cost Associated with Women's Health Diagnostics
An increasing cost of diagnostic tests such as MRI, and CT leads to market hindrance. Diagnostic tests for women's health are expensive, a substantial barrier to market entry. The low-income companies and developing economies are addressing these market constraints in women's health diagnostics. Thus, these factors hamper the market growth.
This women's health diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the women's health diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
North America Women's Health Diagnostics Market Scope
The women's health diagnostics market is segmented on the basis of application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Osteoporosis Testing
- OVC Testing
- OVC tumor marker tests
- OVC diagnostic imaging tests
- Other OVC tests
- Cervical Cancer Testing
- Pap Smears
- HPV testing
- Pap Smears
- HPV Testing
- Prenatal genetic screening and carrier testing
- CF testing
- Down's syndrome
- Edwards' syndrome testing
- Torch testing
- Other prenatal genetic disease tests
- Infectious disease testing
- MRSA testing
- UTI testing
- Hepatitis Testing
- Tuberculosis Testing
- Other Infectious Disease Tests
- Breast Cancer Testing
- Breast Cancer Tumor Marker Tests
- Other Breast Cancer Tests
- STD Testing
- CT/NG testing
- HIV testing
- Other STD tests
- Pregnancy and fertility testing
- Pregnancy testing
- Ovulation prediction kits
- Fertility monitors
- Hospitals and Clinics
- Diagnostic and Imaging Centers
- Home Care Settings
Women's Health Diagnostics Market Regional Analysis/Insights
The women's health diagnostics market is analyzed and market size insights and trends are provided by application and end user as referenced above.
The countries covered in the women's health diagnostics market report are U.S., Canada, and Mexico in North America
U.S. dominates the women's health diagnostics market due to the increasing prevalence of cancer among women, the growing incidence of lifestyle-related disorders, and the adoption of technologically advanced products leading to the market growth. Also, increasing product launches and government initiatives lead to market growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The women's health diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for women's health diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the women's health diagnostics market. The data is available for historic period 2011-2021.
Competitive Landscape and Women's Health Diagnostics Market Share Analysis
The women's health diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, north america presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the women's health diagnostics market.
Some of the major players operating in the women's health diagnostics market are:
- Siemens (Germany)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- Abbott (U.S.)
- BD (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Thermo Fisher Scientific Inc. (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- NeuroLogica Corp.(U.S.)
- Shimadzu Medical (India) pvt. Ltd. (Japan)
- General Electric (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- Sysmex India Pvt. Ltd. (Japan)
- Hitachi, Ltd. (Japan)
- Canon Inc. (Japan)